Commons Sense

House of Commons · Petition P002858

NICE Enhertu Cancer Treatment

18 September 2023

Presented 1 time by 1 MP

NHS

Summarised by AI from the official record, so it can contain mistakes.

Read the full transcript on Parliament.uk

At a glance

This petition concerning nice enhertu cancer treatment was presented to Parliament once by 1 MP.

Issue summary

The petition calls for the National Institute for Health Care and Excellence (NICE) to approve the use of the drug Enhertu for NHS cancer treatment among patients with the HER2 mutation, beyond its current approval for breast cancer only.

Action requested

NICE should take steps to approve the further use of Enhertu in NHS cancer treatments for patients with the HER2 mutation.

Key facts

  • The petition received over 166,000 signatures.
  • Enhertu is currently approved exclusively for breast cancer treatment by NICE.
  • In the United States, Enhertu has been approved for patients with the HER2 mutation.

Presentation timeline

MPs presented this petition on the following dates. Each card shows the presenters and any recorded remarks.

  1. Presented 18 September 2023

    Saqib Bhatti Con Meriden and Solihull East

    Further to the similar change.org petition that received over 166,000 signatures, I formerly present this petition on behalf of my constituent, Elaine Lynch. It calls on the National Institute for Health Care and Excellence to authorise the use of the drug Enhertu for NHS cancer treatment among patients with the HER2 mutation, given that the drug currently holds approval exclusively for breast cancer treatment. The petition states:

▸ Assessment & feedback
Summary accuracy